We are live on ! Find out more
NDRAW

ENDRA Life Sciences Inc. Warrants
NDRAW

Delisted

NDRAW was delisted on the 12th of May, 2022.

Back to rankings

1 hedge funds and large institutions have $0 invested in ENDRA Life Sciences Inc. Warrants in 2022 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

50% less funds holding

Funds holding: 2 → 1 (-1)

100% less capital invested

Capital invested by funds: $4K → $0 (-$4K)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 1

Holders
1
Holders Change
-1
Holders Change %
-50%
% of All Funds
0.02%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
1
Reduced
–
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
UBS Group
UBS Group
Switzerland
+$379

Top Sellers

Rank Fund Capital Flow
1
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$3K
Name Holding Trade Value Shares
Change 		Change in
Stake
Susquehanna International Group
1
Susquehanna International Group
Pennsylvania
– -$3K -33,319 Closed
UBS Group
2
UBS Group
Switzerland
– +$379 +10,233 +155%

NDRAW Hedge Fund Activity: Q1 2022 in Review

1 of the 6,341 institutional investors tracked by Wall St. Rank reported a position in ENDRA Life Sciences Inc. Warrants (NDRAW) for Q1 2022, worth a combined $0 — down 100% from $4K a quarter earlier.

Sellers outnumbered buyers: 1 fund closed out of NDRAW and 0 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 1 added.

The largest buyer was UBS Group, adding an estimated $379. The largest seller was Susquehanna International Group, exiting entirely with an estimated $3K sold.

  • 1 institutional investor held ENDRA Life Sciences Inc. Warrants (NDRAW) as of Q1 2022, down from 2 in Q4 2021.
  • Funds reported $0 of ENDRA Life Sciences Inc. Warrants stock for Q1 2022, down 100% quarter-over-quarter.
  • 0 funds opened new ENDRA Life Sciences Inc. Warrants positions in Q1 2022 and 1 closed out, a net change of -1 holder.
  • The largest ENDRA Life Sciences Inc. Warrants buyer in Q1 2022 was UBS Group, an estimated $379 added.
  • The largest ENDRA Life Sciences Inc. Warrants seller in Q1 2022 was Susquehanna International Group, an estimated $3K sold.

Based on aggregated 13F filings for Q1 2022.